Primary Care Loop Closure Low Across All Test Types
By Lori Solomon HealthDay Reporter
TUESDAY, Nov. 28, 2023 -- Rates of loop closure are low for all test types across all primary care visit modalities but are worse for telehealth visits, according to a study published online Nov. 15 in JAMA Network Open.
Anthony Zhong, from Harvard Medical School in Boston, and colleagues examined the prevalence of diagnostic loop closure for tests and referrals ordered at telehealth visits versus in-person visits. The analysis included test and referral orders for 4,133 patient visits from March 1, 2020, to Dec. 31, 2021, at a large urban hospital-based primary care practice and one affiliated community health center.
The researchers found that 27.8 percent of orders were placed during a telehealth visit, and of the telehealth orders, 42.6 percent were completed within the designated time frame versus 58.4 percent of those ordered during in-person visits and 57.4 percent of those ordered without a visit. In the adjusted analysis, patients with telehealth visits were still less likely to close the loop for all test types versus those with in-person visits (odds ratio, 0.55).
"Failure to close diagnostic loops presents a patient safety challenge in primary care that may be of particular concern during telehealth encounters," the authors write.
Several authors disclosed ties to industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted November 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.